Paul A McNab plans sale of Viavi (NASDAQ: VIAV) shares

Rhea-AI Filing Summary

Viavi Solutions shareholder Paul A McNab has filed a notice to sell 4,638 common shares under Rule 144. The planned sale, to be executed through Morgan Stanley Smith Barney LLC, has an aggregate market value of $119,647.41 and is expected around 02/02/2026 on the NASDAQ.

The notice shows these shares were acquired through restricted stock and performance share awards in 2024 and 2025. It also lists prior sales over the past three months totaling 14,274 common shares for gross proceeds of $249,672.82. Viavi had 231,389,345 common shares outstanding, providing scale context for these transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4638	119647.41	231389345	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/28/2025	Restricted Stock	Issuer			1777	02/28/2025	Not Applicable
Common	09/24/2024	Performance Shares	Issuer			748	09/24/2024	Not Applicable
Common	09/24/2024	Performance Shares	Issuer			2113	09/24/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PAUL A MCNAB 1445 South Spectrum Blvd Suite 102 Chandler AZ 85286	Common	11/26/2025	1657	30065.11
PAUL A MCNAB 1445 South Spectrum Blvd Suite 102 Chandler AZ 85286	Common	11/03/2025	12617	219607.71

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Viavi (VIAV) Form 144 filing by Paul A McNab disclose?

The filing discloses that shareholder Paul A McNab plans to sell 4,638 Viavi common shares under Rule 144. The planned sale’s aggregate market value is $119,647.41, and the shares are expected to be sold on the NASDAQ through Morgan Stanley Smith Barney.

How many Viavi (VIAV) shares is Paul A McNab planning to sell and through which broker?

The notice shows a planned sale of 4,638 Viavi common shares. The transaction is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, with trading on the NASDAQ exchange.

What is the value of the Viavi (VIAV) shares covered by this Form 144 filing?

The planned Rule 144 sale covers Viavi common shares with an aggregate market value of $119,647.41. This figure reflects the market value of the 4,638 shares identified in the filing for potential sale on the NASDAQ through the named broker.

How many Viavi (VIAV) shares has Paul A McNab sold in the past three months?

The document lists past three-month sales totaling 14,274 Viavi common shares. These include 1,657 shares sold on 11/26/2025 and 12,617 shares sold on 11/03/2025, generating combined gross proceeds of $249,672.82 according to the filing.

How were the Viavi (VIAV) shares in the Form 144 acquired?

The shares to be sold were acquired from the issuer as restricted stock and performance shares. The filing shows acquisitions on 02/28/2025 and 09/24/2024 totaling 4,638 common shares, with payment noted as “Not Applicable” for these equity awards.

How many Viavi (VIAV) shares were outstanding when this Form 144 was filed?

The filing reports that 231,389,345 Viavi common shares were outstanding. This figure gives investors a sense of the company’s total share base relative to the 4,638 shares covered by the planned Rule 144 sale described in the notice.